Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714467 · ClinicalTrials.gov registry record · NA
Expert System and Family Assisted Interventions for Chinese Smokers
A NA study of Smoking Cessation, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,280
- Enrollment target
- 1
- Study location
NCT00714467: Completed NA study of Smoking Cessation, sponsored by University of California, San Francisco.
NCT00714467 is a NA study of Smoking Cessation that has completed, run by University of California, San Francisco. The registered enrollment target is 1,280 participants, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (174% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00714467, a NA study of Smoking Cessation, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,280 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, we choose to specifically recruit Chinese, the largest ethnic group of the Asian and Pacific Islander community,2 as an initial step to increase our understanding of the role of family or supportive others in the process of smoking cessation among Asian Americans. We propose the following specific aims for the study: 1. Examine the effectiveness of proactive recruitment of Chinese smokers into a smoking cessation treatment program through their family or friends. 2. Test the efficacy of a family assisted intervention using the stages of change approach in promoting smoking cessation in the context of an expert system intervention. 3. Explore the role of supportive and non-supportive behaviors in relation to both short-term and long-term smoking cessation outcomes in the presence of the expert system intervention.
Conditions Studied
Interventions
- BEHAVIORAL Expert System Only
- BEHAVIORAL Family Assisted
Study Locations (1)
California
- UCSF Langley Porter - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,280 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00714467 record still lists
NCT00714467 is an interventional study that assigns participants to a tested intervention. Its 1,280 participants enrollment target places it among the larger protocols in the corpus, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (174% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Expert System Only is the first listed.
NCT00714467 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00714467 about?
NCT00714467 is a clinical study titled "Expert System and Family Assisted Interventions for Chinese Smokers". In this study, we choose to specifically recruit Chinese, the largest ethnic group of the Asian and Pacific Islander community,2 as an initial step to increase our understanding of the role of family or supportive others in the process of smoking cessation among Asian Americans. We propose the follo...
What is the current status of trial NCT00714467?
This trial is currently completed. It is a NA study. The enrollment target is 1,280 participants. The study started on 2004-08. Estimated completion is 2008-12.
What conditions does trial NCT00714467 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT00714467?
The interventions under investigation include: Expert System Only (BEHAVIORAL), Family Assisted (BEHAVIORAL).
Who is sponsoring clinical trial NCT00714467?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00714467 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00714467's enrollment target sits among peer trials
1,280 17th of 188 higher than 172 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia